Kenvue Stock (KVUE) News Today: Deal Spread Math, Kimberly-Clark Vote Timeline, Tylenol Lawsuits, and Analyst Forecasts (Dec. 19, 2025)
Kenvue Inc. (NYSE: KVUE) — the consumer-health company behind Tylenol, Band-Aid, Listerine, Aveeno, and Neutrogena — is trading in a very particular kind of market right now: not just “up or down,” but “how likely is the Kimberly-Clark deal to close, and what’s the risk premium?” As of Dec. 19, 2025 (19.12.2025), KVUE last traded around $17.10. That comes right after Thursday’s close at $17.10, when the stock fell 1.04% and saw elevated trading volume, according to MarketWatch. marketwatch.com What’s moving Kenvue stock on Dec. 19, 2025 Three forces dominate the current KVUE narrative: The deal that matters: Kimberly-Clark’s acquisition